4//SEC Filing
Pulse Biosciences, Inc. 4
Accession 0001209191-17-032134
$PLSECIK 0001625101operating
Filed
May 11, 8:00 PM ET
Accepted
May 12, 6:17 PM ET
Size
10.1 KB
Accession
0001209191-17-032134
Insider Transaction Report
Form 4
Thaure Thierry B.
Director
Transactions
- Exercise/Conversion
Common Stock
2017-05-12$2.67/sh+10,000$26,700→ 10,000 total - Sale
Common Stock
2017-05-12$23.90/sh−5,000$119,500→ 5,000 total - Sale
Common Stock
2017-05-12$24.90/sh−5,000$124,500→ 0 total - Exercise/Conversion
Stock Option (right to buy)
2017-05-12−10,000→ 50,655 totalExercise: $2.67Exp: 2020-06-01→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest in equal quarterly installments over a three year period commencing on June 1, 2015 and ending on March 1, 2018, subject to the Reporting Person's continued service through each vesting date.
Documents
Issuer
Pulse Biosciences, Inc.
CIK 0001625101
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001625101
Filing Metadata
- Form type
- 4
- Filed
- May 11, 8:00 PM ET
- Accepted
- May 12, 6:17 PM ET
- Size
- 10.1 KB